Skip to main content

La Jolla Pharmaceutical Co

LJPCDelisted Aug 22, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000920465

La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in La Jolla Pharmaceutical Co as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
−4 vs. Q1 2022
Shares held
16.9M
+388.6K (+2.4%) vs. Q1 2022
Total value
$53.9M
−$16.6M (−23.5%) vs. Q1 2022
New holders
2
8 more added
Sold out
6
17 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LJPC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 41 institutions
Q1 2021: 76 institutionsQ2 2021: 62 institutionsQ3 2021: 54 institutionsQ4 2021: 44 institutionsQ1 2022: 45 institutionsQ2 2022: 41 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $53.9M
Q1 2021: $88.2MQ2 2021: $78.6MQ3 2021: $70.9MQ4 2021: $77.8MQ1 2022: $70.4MQ2 2022: $53.9MQ3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding LJPC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 202241$53.9M
Q1 202245$70.4M
Q4 202144$77.8M
Q3 202154$70.9M
Q2 202162$78.6M
Q1 202176$88.2M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding La Jolla Pharmaceutical Co; share changes are against Q1 2022.

Institutions holding LJPC in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC9,607,934$30.6M4.65%00.0%Unchanged
RTW Investments, LP2,327,403$7.42M0.19%00.0%Unchanged
HealthInvest Partners AB1,265,000$4.04M9.30%+558,000+78.9%Added
Vanguard Group Inc825,481$2.63M0.00%00.0%Unchanged
D. E. Shaw & Co., Inc.581,446$1.85M0.00%−18,624−3.1%Reduced
Acadian Asset Management LLC465,247$1.48M0.01%−12,441−2.6%Reduced
BlackRock Inc.418,216$1.33M0.00%−8,297−1.9%Reduced
Tang Kevin C240,000$766.0K99.74%00.0%Unchanged
Geode Capital Management, LLC203,930$650.0K0.00%+1,114+0.5%Added
Bank of New York Mellon Corp122,693$392.0K0.00%−4,391−3.5%Reduced
Millennium Management LLC102,606$327.0K0.00%−36,283−26.1%Reduced
State Street Corp98,941$316.0K0.00%00.0%Unchanged
FMR LLC90,310$288.0K0.00%−131−0.1%Reduced
Northern Trust Corp80,615$257.0K0.00%+562+0.7%Added
Hollencrest Capital Management80,355$256.0K0.03%−2,000−2.4%Reduced
Globeflex Capital L P58,611$187.0K0.05%−34,188−36.8%Reduced
Renaissance Technologies LLC57,500$183.0K0.00%+31,400+120.3%Added
O'Shaughnessy Asset Management, LLC51,017$163.0K0.00%+17,385+51.7%Added
Morgan Stanley43,307$138.0K0.00%−758−1.7%Reduced
Old National Bancorp41,284$132.0K0.00%+41,284New
WealthTrust Axiom LLC25,400$81.0K0.03%00.0%Unchanged
Susquehanna International Group, LLP22,193$71.0K0.00%+10,647+92.2%Added
Ritholtz Wealth Management16,716$53.0K0.00%+1,685+11.2%Added
Schonfeld Strategic Advisors LLC15,500$49.0K0.00%−10,600−40.6%Reduced
Running Point Capital Advisors, LLC10,000$32.0K0.02%00.0%Unchanged
The PNC Financial Services Group, Inc.7,000$22.0K0.00%00.0%Unchanged
Bank of America Corp5,407$17.0K0.00%−1,185−18.0%Reduced
Barclays PLC5,352$17.0K0.00%00.0%Unchanged
Meeder Asset Management Inc4,159$13.0K0.00%−153−3.5%Reduced
Wells Fargo & Company2,614$9.00K0.00%+2+0.1%Added
Ellis Investment Partners, LLC2,800$8.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)2,083$7.00K0.00%−1,486−41.6%Reduced
Advisor Group Holdings, Inc.1,400$4.00K0.00%+1,400New
SOA Wealth Advisors, LLC.1,045$3.00K0.00%00.0%Unchanged
Tyler-Stone Wealth Management500$2.00K0.00%00.0%Unchanged
UBS Group AG350$1.00K0.00%−1,868−84.2%Reduced
Group One Trading, L.P.333$1.00K0.00%−261−43.9%Reduced
Royal Bank of Canada225$1.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA1$30.00%00.0%Unchanged
JPMorgan Chase & Co47$00.00%−341−87.9%Reduced
Simplex Trading, LLC63$00.00%−267−80.9%Reduced
Citadel Advisors LLC0$00.00%−50,873−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−34,900−100.0%Sold out
Two Sigma Investments, LP0$00.00%−27,544−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−13,718−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−13,541−100.0%Sold out
American Portfolios Advisors0$00.00%−1,000−100.0%Sold out